Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bixia Tang

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Nucleic Acids Research|October 16, 2023
TCOD: an integrated resource for tropical cropsHailong Kang, Tianhao Huang, Guangya Duan, et al.
Annals of Surgical Oncology|May 12, 2018
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma PatientsChuanLiang Cui, Bin Lian, Li Zhou, et al.
Journal for Immunotherapy of Cancer|February 23, 2022
Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysisSiming Li, Xiaowen Wu, Xieqiao Yan, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insightsXuan Wang, Hui Tian, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2018
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 studyXinan Sheng, Dengfeng Cao, Jianlin Yuan, et al.
The Oncologist|October 17, 2024
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinomaBixia Tang, Jun Xiao, Zhihong Chi, et al.
Frontiers in Oncology|June 7, 2021
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy-<i>Ad hoc</i> Analyses of Pooled Data From Two Clinical TrialsXue Bai, Jie Dai, Caili Li, et al.
Frontiers in Oncology|September 10, 2021
Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa TrialLili Mao, Ya Ding, Xue Bai, et al.
Biotechnology for Biofuels|January 9, 2016
SorGSD: a sorghum genome SNP databaseHong Luo, Wenming Zhao, Yanqing Wang, et al.
Signal Transduction and Targeted Therapy|November 21, 2024
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trialJiayong Liu, Xuan Wang, Zhongwu Li, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Nucleic Acids Research|October 16, 2023
TCOD: an integrated resource for tropical cropsHailong Kang, Tianhao Huang, Guangya Duan, et al.
Annals of Surgical Oncology|May 12, 2018
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma PatientsChuanLiang Cui, Bin Lian, Li Zhou, et al.
Journal for Immunotherapy of Cancer|February 23, 2022
Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysisSiming Li, Xiaowen Wu, Xieqiao Yan, et al.
Journal for Immunotherapy of Cancer|February 6, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insightsXuan Wang, Hui Tian, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2018
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 studyXinan Sheng, Dengfeng Cao, Jianlin Yuan, et al.
The Oncologist|October 17, 2024
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinomaBixia Tang, Jun Xiao, Zhihong Chi, et al.
Frontiers in Oncology|June 7, 2021
Risk Models for Advanced Melanoma Patients Under Anti-PD-1 Monotherapy-<i>Ad hoc</i> Analyses of Pooled Data From Two Clinical TrialsXue Bai, Jie Dai, Caili Li, et al.
Frontiers in Oncology|September 10, 2021
Overall Survival of Patients With Unresectable or Metastatic BRAF V600-Mutant Acral/Cutaneous Melanoma Administered Dabrafenib Plus Trametinib: Long-Term Follow-Up of a Multicenter, Single-Arm Phase IIa TrialLili Mao, Ya Ding, Xue Bai, et al.
Biotechnology for Biofuels|January 9, 2016
SorGSD: a sorghum genome SNP databaseHong Luo, Wenming Zhao, Yanqing Wang, et al.
Signal Transduction and Targeted Therapy|November 21, 2024
Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trialJiayong Liu, Xuan Wang, Zhongwu Li, et al.
Pageof 12